Cargando…

Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities

[Image: see text] The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is an urgent global need, thus different strategies targeting either virus or host cell are still under inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannalire, Rolando, Cerchia, Carmen, Beccari, Andrea R., Di Leva, Francesco Saverio, Summa, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688049/ https://www.ncbi.nlm.nih.gov/pubmed/33186044 http://dx.doi.org/10.1021/acs.jmedchem.0c01140

Ejemplares similares

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells
por: Cannalire, Rolando, et al.
Publicado: (2020)

Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination
por: Stefanelli, Irina, et al.
Publicado: (2023)

Easy access to α-ketoamides as SARS-CoV-2 and MERS M(pro) inhibitors via the PADAM oxidation route
por: Pelliccia, Sveva, et al.
Publicado: (2022)

Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities
por: Corona, Angela, et al.
Publicado: (2022)

Special Issue “Advances in Antiviral Agents against SARS-CoV-2 and Its Variants”
por: Esposito, Francesca, et al.
Publicado: (2023)

Visible-Light Photocatalytic Functionalization of Isocyanides for the Synthesis of Secondary Amides and Ketene Aminals
por: Cannalire, Rolando, et al.
Publicado: (2020)

Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
por: Grottesi, Alessandro, et al.
Publicado: (2020)

Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses
por: Fumagalli, Valeria, et al.
Publicado: (2023)

Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
por: Varahachalam, Sree Pooja, et al.
Publicado: (2021)

Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex
por: Deval, Jerome, et al.
Publicado: (2022)

State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2
por: Tanimoto, Shoichi, et al.
Publicado: (2022)

The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2
por: Jin, Zhenming, et al.
Publicado: (2021)

Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen
por: Kuzikov, Maria, et al.
Publicado: (2021)

State of the Art and Future Opportunities in MRI-Guided Robot-Assisted Surgery and Interventions
por: Su, Hao, et al.
Publicado: (2022)

Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives
por: Cocetta, Veronica, et al.
Publicado: (2021)

Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)

Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease
por: Manelfi, Candida, et al.
Publicado: (2021)

SARS-CoV-2: an opportunity for hospital pharmacy
por: Claramunt García, Raquel, et al.
Publicado: (2022)

SARS-CoV-2-Induced Myocarditis: A State-of-the-Art Review
por: Nappi, Francesco, et al.
Publicado: (2023)

ANALYZE OF THE GENE EXPRESSION PROFILES OF SARS-COV-2-ASSOCIATED RECEPTORS AND PROTEASES IN HUMAN ENDOMETRIUM DURING ART PRACTICE
por: Haouzi, Delphine, et al.
Publicado: (2021)

Structure of SARS-CoV-2 main protease in the apo state
por: Zhou, Xuelan, et al.
Publicado: (2020)

Enhancement of SARS-CoV Infection by Proteases
por: Matsuyama, Shutoku, et al.
Publicado: (2006)

Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19
por: von Hentig, Nils
Publicado: (2021)

Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir
por: Bafna, Khushboo, et al.
Publicado: (2021)

Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
por: Citarella, Andrea, et al.
Publicado: (2023)

Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
por: Shetty, Rohit, et al.
Publicado: (2020)

Wheat end-use quality: State of art, genetics, genomics-assisted improvement, future challenges, and opportunities
por: Subedi, Madhav, et al.
Publicado: (2023)

“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool
por: Manelfi, Candida, et al.
Publicado: (2021)

Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations
por: Nguyen, Hoang Linh, et al.
Publicado: (2020)

Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics
por: Alhadrami, Hani A., et al.
Publicado: (2021)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
por: McElvaney, Oisin F., et al.
Publicado: (2022)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

Structure and function of SARS-CoV-2 polymerase
por: Hillen, Hauke S
Publicado: (2021)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir
por: Paciaroni, Alessandro, et al.
Publicado: (2023)

Hemorrhoids Embolization: State of the Art and Future Directions
por: Rebonato, Alberto, et al.
Publicado: (2021)

Polymer Conjugates of Antimicrobial Peptides (AMPs) with d-Amino Acids (d-aa): State of the Art and Future Opportunities
por: Bellotto, Ottavia, et al.
Publicado: (2022)

Telemedicine: A cornerstone of healthcare assistance during the SARS-Cov2 pandemic outbreak but also a great opportunity for the near future
por: Tartaglia, Edoardo, et al.
Publicado: (2022)

State of the art in epitope mapping and opportunities in COVID-19
por: Hamed, Samira M, et al.
Publicado: (2023)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06nsidcqplco1pj5q1l8vqkp4v